Valeo Financial Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Valeo Financial Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,300	Closed	–	–	1724
2019 Q1	$0	Hold	2,300	–	–	﹤0.01%	1678
2018 Q4	$0	Hold	2,300	–	–	﹤0.01%	1859
2018 Q3	$1K	Hold	2,300	–	–	﹤0.01%	1750
2018 Q2	$4K	Buy	+2,300	New	+$3.98K	﹤0.01%	1225

Valeo Financial Advisors's SGYP Position: Q2 2019 in Review

Valeo Financial Advisors sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2019, closing a stake of 2,300 shares.

Valeo Financial Advisors first reported a position in SGYP in Q2 2018 and held it in 4 quarters. The position peaked at $4K in Q2 2018. 2 funds tracked by Wall St. Rank hold SGYP as of Q2 2019.

Valeo Financial Advisors reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2019 after selling out during the quarter.
Valeo Financial Advisors sold 2,300 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2019.
Valeo Financial Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2018 and held it in 4 quarters.
Valeo Financial Advisors's Synergy Pharmaceuticals, Inc Common Stock position peaked at $4K in Q2 2018.
2 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2019.

Based on Valeo Financial Advisors's 13F filing for Q2 2019, filed 10 Jul 2019.